Polycystic ovary syndrome (PCOS) is a condition that affects hormonal balance, affecting 6-10% of reproductive-aged women ( 1 )
Researchers from Loyola University Chicago suggest GLP-1 and GIP drugs may provide innovative treatment strategies for opioid and alcohol use disorders
The peptide aids wound healing and reduces inflammation, which may reduce the harmful effects of UV exposure (1)
Some things to consider: Watch for side effects like loose stools, nausea, and drowsiness
Every four weeks, the dose is gradually escalated (to 0.5 mg, 1.0 mg, 1.7 mg, and finally the maintenance dose of 2.4 mg per week) until the patient reaches their target clinical maintenance level
Phase 2 extension (additional 52 weeks) will refine maintenance dosing strategies